• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Dime Bancorp

Dime Bancorp

  1. Research and Markets: EpiCast Report: Diabetic Macular Edema - Epidemiology Forecast to 2023

    Research and Markets: EpiCast Report: Diabetic Macular Edema - Epidemiology Forecast to 2023

  2. pSivida Corp. Reports ILUVIEN® for Chronic Diabetic Macular Edema Receives Marketing Authorization in Sweden, 10th EU Approval

    pSivida Corp. Reports ILUVIEN® for Chronic Diabetic Macular Edema Receives Marketing Authorization in Sweden, 10th EU Approval

  3. Regeneron Announces Submission of Application for EYLEA® (aflibercept) Injection in Japan for Macular Edema Following Branch Retinal Vein Occlusion

    Regeneron Announces Submission of Application for EYLEA® (aflibercept) Injection in Japan for Macular Edema Following Branch Retinal Vein Occlusion

  4. Research and Markets: Methanol Markets in China 2014-2023

    Research and Markets: Methanol Markets in China 2014-2023

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.